We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Got Creative With Inspections During Pandemic, Plans to Stay That Way
FDA Got Creative With Inspections During Pandemic, Plans to Stay That Way
The pandemic forced the FDA to be far more innovative in its efforts to inspect drug manufacturing facilities, and the agency plans to incorporate these new modalities into its site surveillance process going forward.